Prostate Cancer Clinical Trials

Norton Cancer Institute is at the forefront of cancer treatment research. As principal investigators on numerous trials, our specialist physicians have access to innovative treatments.

Learn more about participating in a clinical trial at Norton Healthcare.

Active prostate cancer clinical trials include:

Prostate Cancer

A Phase 2 Efficacy and Safety Study of Niraparib in Men with Metastatic Castration-resistant Prostate Cancer and DNA-Repair Anomalies

Prostate Cancer

CA209-9KD Study: “A Phase 2 Study of Nivolumab in Combination with Either Rucaparib, Docetaxel, or Enzalutamide in Men with Castration-resistant Metastatic Prostate Cancer (CheckMate 9KD: CHECKpoint pathway and nivoluMAb clinical Trial Evaluation 9KD)”

Prostate Cancer

A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Subjects with Metastatic Prostate Cancer

Prostate Cancer

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate plus Prednisone with or without Abemaciclib in Patients with Metastatic Castration-Resistant Prostate Cancer

Prostate Cancer

VISION: An International, Prospective, Open Label, Multicenter, Randomized Phase 3 Study of 177Lu-PSMA-617 in the Treatment of Patients With Progressive PSMA-positive Metastatic Castration-resistant Prostate Cancer (mCRPC)

Prostate Cancer

An Extended/Phase 2, Multi-Center, Randomized, Open-Label Study to Evaluate the Safety and Tolerability of Proxalutamide (GT0918) in Subjects with Metastatic Castrate Resistant Prostate Cancer (mCRPC) who Failed Either Abiraterone or Enzalutamide

Prostate Cancer

Biomarker Study to Determine Frequency of DNA-repair Defects in Men with Metastatic Prostate Cancer

Small Cell Lung Cancer (SCLC)

A Phase 1 Dose Escalation and Expanded Cohort Study of PF-06821497 in the treatment of adult patients with Relapsed/Refractory Small Cell Lung Cancer (SCLC), Castration Resistant Prostate Cancer (CRPC), and Follicular Lymphoma (FL)

Cancer – 4673

Appointments

Cancer care that isn’t too far from home.

(502) 629-HOPE (4673)


Request an Appointment Online

Clinical trials

Clinical Trials

Learn more about clinical trials at Norton Healthcare
(502) 629-3501

Cokie Roberts’ 17-year breast cancer survival points to medical advances

When television journalist Cokie Roberts was diagnosed with breast cancer in 2002, she had reason to be optimistic. The 15-year survival rate for breast cancer patients was about 70%, meaning the odds were with her, […]

Read Full Story

Using vaccines to treat brain cancer: 4 things to know about this immunotherapy trial

Immunotherapy is a method of treating cancer, and new immune treatments are being studied across the country. Norton Cancer Institute is participating in a clinical trial conducted by AIVITA Biomedical Inc. to study whether a […]

Read Full Story

Why do I ride in Bike to Beat Cancer? Because I miss you, Rhonda

Ever have that work friend that turns into a real friend? Rhonda Hoffman was that real friend. We met not long after I moved here from Cincinnati for a career change. After several years, we […]

Read Full Story

Thomas M. Woodcock, M.D., to retire; pioneered cancer care in Louisville and Southern Indiana

Thomas M. Woodcock, M.D., came to Louisville in 1981 and was one of four founders of what is now Norton Cancer Institute. After almost 40 years as a medical oncologist, Dr. Woodcock plans to retire […]

Read Full Story

New dad gets ependymoma brain tumor diagnosis one day after son’s birth

March 2016 was a life-changing time for the Davis family. On March 23, Matt Davis and his wife, Hailey, celebrated the birth of their son, Finley. The next day, Matt learned he had a rare […]

Read Full Story
Related Stories

Cokie Roberts’ 17-year breast cancer survival points to medical advances

When television journalist Cokie Roberts was diagnosed with breast cancer in 2002, she had reason to be optimistic. The 15-year survival rate for breast cancer patients was about 70%, meaning the odds were with her, […]

Read Full Story

Using vaccines to treat brain cancer: 4 things to know about this immunotherapy trial

Immunotherapy is a method of treating cancer, and new immune treatments are being studied across the country. Norton Cancer Institute is participating in a clinical trial conducted by AIVITA Biomedical Inc. to study whether a […]

Read Full Story

Why do I ride in Bike to Beat Cancer? Because I miss you, Rhonda

Ever have that work friend that turns into a real friend? Rhonda Hoffman was that real friend. We met not long after I moved here from Cincinnati for a career change. After several years, we […]

Read Full Story

Thomas M. Woodcock, M.D., to retire; pioneered cancer care in Louisville and Southern Indiana

Thomas M. Woodcock, M.D., came to Louisville in 1981 and was one of four founders of what is now Norton Cancer Institute. After almost 40 years as a medical oncologist, Dr. Woodcock plans to retire […]

Read Full Story

New dad gets ependymoma brain tumor diagnosis one day after son’s birth

March 2016 was a life-changing time for the Davis family. On March 23, Matt Davis and his wife, Hailey, celebrated the birth of their son, Finley. The next day, Matt learned he had a rare […]

Read Full Story

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.